These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 20080426)

  • 41. Homozygosity for the common GAA gene splice site mutation c.-32-13T>G in Pompe disease is associated with the classical adult phenotypical spectrum.
    Musumeci O; Thieme A; Claeys KG; Wenninger S; Kley RA; Kuhn M; Lukacs Z; Deschauer M; Gaeta M; Toscano A; Gläser D; Schoser B
    Neuromuscul Disord; 2015 Sep; 25(9):719-24. PubMed ID: 26231297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical features and acid alpha-glucosidase gene mutation in 7 Chinese patients with glycogen storage disease type II].
    Liu Q; Zhao J; Wang ZX; Zhang W; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(25):1981-5. PubMed ID: 24169249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reevaluating the pathogenicity of the mutation c.1194 +5 G>A in GAA gene by functional analysis of RNA in a 61-year-old woman diagnosed with Pompe disease by muscle biopsy.
    Amiñoso C; Gordillo-Marañón M; Hernández J; Solera J
    Neuromuscul Disord; 2019 Mar; 29(3):187-191. PubMed ID: 30770309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and molecular genetic study of infantile-onset Pompe disease in Chinese patients: identification of 6 novel mutations.
    Fu L; Qiu W; Yu Y; Guo Y; Zhao P; Zhang X; Liu C; Li F; Huang H; Huang M; Chen S
    Gene; 2014 Feb; 535(1):53-9. PubMed ID: 24269976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe Registry.
    Reuser AJJ; van der Ploeg AT; Chien YH; Llerena J; Abbott MA; Clemens PR; Kimonis VE; Leslie N; Maruti SS; Sanson BJ; Araujo R; Periquet M; Toscano A; Kishnani PS; On Behalf Of The Pompe Registry Sites
    Hum Mutat; 2019 Nov; 40(11):2146-2164. PubMed ID: 31342611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Novel Compound Heterozygous Mutations of GAA Gene in Mainland Chinese Patient with Classic Infantile-Onset Pompe Disease.
    Li J; Cui Y; Wang X; Wang Q; Wang H; Yan B
    Int Heart J; 2020 Jan; 61(1):178-182. PubMed ID: 31875618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies.
    Preisler N; Lukacs Z; Vinge L; Madsen KL; Husu E; Hansen RS; Duno M; Andersen H; Laub M; Vissing J
    Mol Genet Metab; 2013 Nov; 110(3):287-9. PubMed ID: 24011652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutations in GAA Gene in Tunisian Families with Infantile Onset Pompe Disease: Novel Mutation and Structural Modeling Investigations.
    Alila-Fersi O; Aloulou H; Werteni I; Mahfoudh N; Chabchoub I; Kammoun H; Keskes L; Hachicha M; Belguith N; Fakhfakh F
    J Mol Neurosci; 2020 Jul; 70(7):1100-1109. PubMed ID: 32125626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted population screening of late onset Pompe disease in unspecified myopathy patients for Korean population.
    Lee JH; Shin JH; Park HJ; Kim SZ; Jeon YM; Kim HK; Kim DS; Choi YC
    Neuromuscul Disord; 2017 Jun; 27(6):550-556. PubMed ID: 28433475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three patients with glycogen storage disease type II and the mutational spectrum of GAA in Korean patients.
    Park HD; Lee DH; Choi TY; Lee YK; Lee SY; Kim JW; Ki CS; Lee YW
    Ann Clin Lab Sci; 2013; 43(3):311-6. PubMed ID: 23884227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutations.
    Oba-Shinjo SM; da Silva R; Andrade FG; Palmer RE; Pomponio RJ; Ciociola KM; S Carvalho M; Gutierrez PS; Porta G; Marrone CD; Munoz V; Grzesiuk AK; Llerena JC; Berditchevsky CR; Sobreira C; Horovitz D; Hatem TP; Frota ER; Pecchini R; Kouyoumdjian JA; Werneck L; Amado VM; Camelo JS; Mattaliano RJ; Marie SK
    J Neurol; 2009 Nov; 256(11):1881-90. PubMed ID: 19588081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease.
    Tortorelli S; Eckerman JS; Orsini JJ; Stevens C; Hart J; Hall PL; Alexander JJ; Gavrilov D; Oglesbee D; Raymond K; Matern D; Rinaldo P
    Genet Med; 2018 Aug; 20(8):840-846. PubMed ID: 29095812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GAA gene mutation detection following clinical evaluation and enzyme activity analysis in Azeri Turkish patients with Pompe disease.
    Gharesouran J; Jalaiei A; Hosseinzadeh A; Ghafouri-Fard S; Mokhtari Z; Ghahremanzadeh K; Rezazadeh N; Shiva S; Sadeghvand S; Taheri M; Rezazadeh M
    Metab Brain Dis; 2020 Oct; 35(7):1127-1134. PubMed ID: 32504392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and GAA gene mutation analysis in 21 Chinese patients with classic infantile pompe disease.
    Su X; Sheng H; Huang Y; Li X; Zhang W; Zhao X; Li C; Liu L
    Eur J Med Genet; 2020 Dec; 63(12):103997. PubMed ID: 32711049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic implications of pathogenic variant types in Pompe disease.
    Viamonte MA; Filipp SL; Zaidi Z; Gurka MJ; Byrne BJ; Kang PB
    J Hum Genet; 2021 Nov; 66(11):1089-1099. PubMed ID: 33972680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A genetic modifier of symptom onset in Pompe disease.
    Bergsma AJ; In 't Groen SLM; van den Dorpel JJA; van den Hout HJMP; van der Beek NAME; Schoser B; Toscano A; Musumeci O; Bembi B; Dardis A; Morrone A; Tummolo A; Pasquini E; van der Ploeg AT; Pijnappel WWMP
    EBioMedicine; 2019 May; 43():553-561. PubMed ID: 30922962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel GAA mutations in patients with Pompe disease.
    Turaça LT; de Faria DO; Kyosen SO; Teixeira VD; Motta FL; Pessoa JG; Rodrigues E Silva M; de Almeida SS; D'Almeida V; Munoz Rojas MV; Martins AM; Pesquero JB
    Gene; 2015 Apr; 561(1):124-31. PubMed ID: 25681614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy.
    Pascarella A; Terracciano C; Farina O; Lombardi L; Esposito T; Napolitano F; Franzese G; Panella G; Tuccillo F; la Marca G; Bernardini S; Boffo S; Giordano A; Di Iorio G; Melone MAB; Sampaolo S
    J Cell Physiol; 2018 Aug; 233(8):5829-5837. PubMed ID: 29215735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Three cases of multi-generational Pompe disease: Are current practices missing diagnostic and treatment opportunities?
    McIntosh P; Austin S; Sullivan J; Bailey L; Bailey C; Viskochil D; Kishnani PS
    Am J Med Genet A; 2017 Oct; 173(10):2628-2634. PubMed ID: 28763149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interpretation of acid α-glucosidase activity in creatine kinase elevation: A case of Becker muscular dystrophy.
    Oitani Y; Ishiyama A; Kosuga M; Iwasawa K; Ogata A; Tanaka F; Takeshita E; Shimizu-Motohashi Y; Komaki H; Nishino I; Okuyama T; Sasaki M
    Brain Dev; 2018 Oct; 40(9):837-840. PubMed ID: 29778277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.